Simple Summary Endocrine therapy taken after primary breast cancer treatment helps
prevent breast cancer recurrence. However, many women are unable to adhere to …

Background Adjuvant endocrine therapy (AET) reduces the risk of breast cancer recurrence
and mortality. However, up to three-quarters of women with breast cancer do not take AET …

Purpose Adherence and persistence to adjuvant hormone therapy (AHT) are seldom
maintained among early-stage hormone receptor-positive breast cancer (BC) survivors …

Background Medication adherence is crucial for improving clinical outcomes in the treatment
of patients. We evaluate the effect of short message service (SMS) reminder on medication …

Background Globally, breast cancer has been identified as the most common cancer among
women. The clinical efficacy of adjuvant oral antiestrogen therapy—including tamoxifen and …

Background In breast cancer patients, adherence to adjuvant hormone therapy (AHT) is
uncertain. Seven in every 10 patients were hormone receptor positive and adjuvant …

Breast cancer survival has improved with significant progress in treatment and disease
management. However, compliance with treatment varies. Treatment guidelines for older …

Background Non-metastatic breast cancer treatment is mainly based on surgery, with or
without chemotherapy, radiotherapy and/or hormone therapy. To reduce the risk of hormone …

Introduction Adherence to oral endocrine therapy (OET) reduces recurrence risk for
hormone receptor (HR)-positive breast cancer (BC). Refill data accessed through electronic …

Purpose To identify a structure to explain the relationship between socio-clinico factors,
necessity-concerns beliefs, and perceived barriers to adherence with adjuvant endocrine …